STIM:NASDAQ
Neuronetics Inc
$2.11
arrow_upward
+1.44%(+0.030) 1D
Oct 23, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for STIM...
Open
$2.08
High
$2.18
Low
$2.02
Mkt. cap
160.78M
Avg. vol.
1.04M
Volume
0.00
52-wk high
$3.44
52-wk low
$0.80
EPS
-$0.44
Beta
1.19
Shares outstanding
76.20M
No. of employees
658
Open
$2.08
High
$2.18
Low
$2.02
Mkt. cap
160.78M
Avg. vol.
1.04M
Volume
0.00
52-wk high
$3.44
52-wk low
$0.80
EPS
-$0.44
Beta
1.19
Shares outstanding
76.20M
No. of employees
658
News stories
From web sources and news partners
富途牛牛
·
1 day ago
The highlight of earnings season is here: more than one-third of S&P 500 companies will report their results this week.
Traders Union
·
8 hours ago
S&P 500 has averaged 1.9 percent gain in November since 1950, Phil Rosen notes
BeInCrypto
·
5 hours ago
Cramer Beat the S&P At His Hedge Fund But Advises Retail to Join The Index
FXLeaders
·
1 hour ago
Dow Jones Futures and Nasdaq Rebound as Oil Prices Ease Ahead of Fed Decision
Profile
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device."
They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head. Wikipedia
About Neuronetics Inc
CEO-
Employees658
Founded2003
HeadquartersMalvern, Pennsylvania, United States
SectorMedical device
Websiteneurostar.com